Hims & Hers raised its full-year 2026 revenue guidance to a range of $2.8 billion to $3 billion, representing growth of 19% to 28% from 2025 levels, and updated adjusted EBITDA guidance to a range of $275 million to $350 million.
Loss of focus Inflammation Slow Muscle Development & Recovery Lowered Metabolism Weight Gain Lack of energy B12 Injections Perfect for Addressing
Where is this most needed, and what is the most desirable characteristic of it
Klebanoff: Prior authorization requires clinicians to justify a patients need for treatment and get insurer approval for coverage
Pairing Semaglutide with protein-forward meals, fiber, hydration, and light strength work can help preserve lean muscle while your body taps into fat stores
Our roundup of the best GLP-1 tracker apps compares the top choices, and our free GLP-1 tracker guide explains exactly what to log and why